Identification and Characterization of Nonalcoholic Fatty Liver Disease

被引:4
|
作者
Goldshtein, Inbal [1 ]
Chodick, Gabriel [1 ,2 ]
Kochba, Ilan [3 ]
Gal, Nitsan [3 ]
Webb, Muriel [4 ,5 ]
Shibolet, Oren [2 ,5 ]
机构
[1] Maccabi Healthcare Serv, Maccabitech Inst Res & Innovat, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Gilead Sci, Europe Middle East & Africa Med Affairs, Hod Hasharon, Israel
[4] Maccabi Healthcare Serv, Inst Radiol, Tel Aviv, Israel
[5] Tel Aviv Sourasky Med Ctr, Dept Gastroenterol & Hepatol, Tel Aviv, Israel
关键词
D O I
10.1016/j.cgh.2019.08.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1887 / 1889
页数:3
相关论文
共 50 条
  • [41] Identification of 8-miRNAs as biomarkers for nonalcoholic fatty liver disease
    Yu, Yuanjie
    Zhu, Jie
    Liu, Juan
    Huang, Mengjun
    Wan, Jin-Xiang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 17361 - 17369
  • [42] Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease
    Jifeng Liu
    Yiming Li
    Jingyuan Ma
    Xing Wan
    Mingjian Zhao
    Yunshu Zhang
    Dong Shang
    Lipids in Health and Disease, 22
  • [43] IDENTIFICATION OF NONALCOHOLIC FATTY LIVER DISEASE IN PERSONS UNDERGOING BARIATRIC SURGERY
    Sharpton, Suzanne R.
    Thu Nguyen
    Terrault, Norah
    HEPATOLOGY, 2019, 70 : 744A - 745A
  • [44] Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease
    Wu C.
    Liu X.
    Zhong L.
    Zhou Y.
    Long L.
    Yi T.
    Chen S.
    Li Y.
    Chen Y.
    Shen L.
    Zeng Q.
    Tang S.
    Oxidative Medicine and Cellular Longevity, 2023, 2023
  • [45] Identification of high-risk subjects in nonalcoholic fatty liver disease
    Stern, Christiane
    Castera, Laurent
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S196 - S206
  • [46] IDENTIFICATION OF THE SARCOPENIC SIGNALING PATHWAY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Kuwashiro, Takuya
    Tanaka, Kenichi
    Hyogo, Hideyuki
    Nakajima, Atsushi
    Takahashi, Hirokazu
    HEPATOLOGY, 2021, 74 : 1112A - 1112A
  • [47] Identification and immunological characterization of lipid metabolism-related molecular clusters in nonalcoholic fatty liver disease
    Liu, Jifeng
    Li, Yiming
    Ma, Jingyuan
    Wan, Xing
    Zhao, Mingjian
    Zhang, Yunshu
    Shang, Dong
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [48] Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease?
    Softic, Samir
    Kahn, C. Ronald
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 143 - 143
  • [49] Association of nonalcoholic fatty liver disease with insulin resistance -: Is OGTT indicated in nonalcoholic fatty liver disease?
    Sargin, M
    Uygur-Bayramiçli, O
    Sargin, H
    Orbay, E
    Yayla, A
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 37 (05) : 399 - 402
  • [50] Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease
    Anand, Abhinav
    Singh, Amit A.
    Elhence, Anshuman
    Vaishnav, Manas
    Biswas, Sagnik
    Gunjan, Deepak
    Gamanagatti, Shivanand R.
    Nayak, Baibaswata
    Kumar, Ramesh
    Shalimar
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 362 - 371